Learn about our ongoing projects, clinical trials, and research publications to learn about recent advancements in autoimmune research.
-
A central resource that collects, stores, and manages biological samples to support cutting-edge research on autoimmune diseases.
-
Focused on identifying new biomarkers to enable earlier and more accurate diagnosis of autoimmune diseases.
-
Dedicated to making research findings accessible, bridging the gap between scientific discoveries and practical, patient-centered information.
-
Harnesses AI and data science to develop predictive models that improve diagnosis, treatment, and personalized care in autoimmune research.
-
Aims to tailor treatments to individuals based on unique genetic and molecular profiles, enhancing the effectiveness of therapies.
-
Conducts rigorous trials to evaluate new treatments, ensuring safe and effective options for patients with autoimmune conditions.
Current Research Projects
CLIMB
Autoantibodies are proteins that mistakenly attack the body’s own tissues and can interact with other proteins in people with autoimmune inflammatory myopathies (AIM). We explore specific blood protein combinations that could lead to a test guiding treatment decisions and improving outcomes for those affected by AIM. Funded by Arthritis Society.
GAPS
We will examine the level of lupus awareness across the country using GoogleTrends. Supported by Lupus Canada.
See our results here!
ANA Reader©
Anti-nuclear antibody (ANA) is a blood test to diagnose many autoimmune disorders. We developed a machine-learning algorithm that can predict ANA patterns, speeding up the rate at which these tests are performed and increasing their accuracy. Funded by the McCaig Institute SPARC grant.
SPIN
Sporadic inclusion body myositis (sIBM) is a rare muscle disease that is often challenging to diagnose. We discovered several novel sIBM biomarkers involved in the immune, inflammatory, and degenerative pathways that may aid in the early diagnosis and our understanding of disease pathogenesis. Funded by the McCaig Institute SPARC grant.
RAAISE
Increase access to autoimmune diagnostic testing in remote communities including Africa and Indigenous communities. Funded by the University of Calgary Department of Medicine Clinical Research Fund and Astrazeneca.
Lupus Calculator
Patients diagnosed with systemic lupus erythematosus (SLE) have been shown to have an increased risk of developing cardiovascular events (CVDs), such as strokes and heart attacks. We created a calculator that can predict the risk of CVDs in SLE patients, using both traditional biomarkers of CVD, as well as SLE biomarkers. Funded by CIHR.
See our results here!